肿瘤细胞治疗研究
FRONTIER PAPERS
Multimodal C9-66 CAR-T cell immunotherapy improves outcome in preclinical models of pancreatic cancer.
C9-66 CAR-T 细胞经代谢优化与 TME 重编程，代表一种肿瘤特异性、可临床转化的免疫治疗策略，适用于 PDAC 及其他表达 ofCS 的实体瘤。
Protein tyrosine kinases in dendritic cell-mediated anti-cancer immunity.
The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy.
FNDC4 Drives Metastasis and Immune Evasion in Pancreatic Cancer.
CAR-T Cell Exhaustion in Cancer over the Past Decade: Mitochondrial Metabolism as a Target for Counteraction.
Senescent Tumoral HLA-E Reshapes Microenvironment through Impairing NK Cell-Dendritic Cell-T Cell Network in Malignant Pleural Effusion from Lung Canc
Editorial: A new perspective on the importance of dendritic cells in cancer immunity: from bench to patient's bedside.
Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy.
CD70-targeted cancer theranostics: Progress and challenges.
Advances in IL-15-Based Cancer Immunotherapy and Divergent Immunological Effects of IL-2 and IL-15 Signaling via the Shared IL-2Rβγ Receptor.
MEMBER ACCOUNT
登录成功会直接打开下一页。
